Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer

Abnormal ion channel expression distinguishes several types of carcinoma. Here, we explore the relationship between voltage-gated sodium channels (VGSC) and epithelial ovarian cancer (EOC). We find that EOC cell lines express most VGSC, but at lower levels than fallopian tube secretory epithelial ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Iris S. Brummelhuis, Stephen J. Fiascone, Kathleen T. Hasselblatt, Gyorgy Frendl, Kevin M. Elias
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/835024f64c6d47a0aba2f1c716255950
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:835024f64c6d47a0aba2f1c716255950
record_format dspace
spelling oai:doaj.org-article:835024f64c6d47a0aba2f1c7162559502021-11-11T15:31:59ZVoltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer10.3390/cancers132154372072-6694https://doaj.org/article/835024f64c6d47a0aba2f1c7162559502021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5437https://doaj.org/toc/2072-6694Abnormal ion channel expression distinguishes several types of carcinoma. Here, we explore the relationship between voltage-gated sodium channels (VGSC) and epithelial ovarian cancer (EOC). We find that EOC cell lines express most VGSC, but at lower levels than fallopian tube secretory epithelial cells (the cells of origin for most EOC) or control fibroblasts. Among patient tumor samples, lower <i>SCN8A</i> expression was associated with improved overall survival (OS) (median 111 vs. 52 months; HR 2.04 95% CI: 1.21–3.44; <i>p</i> = 0.007), while lower <i>SCN1B</i> expression was associated with poorer OS (median 45 vs. 56 months; HR 0.69 95% CI 0.54–0.87; <i>p</i> = 0.002). VGSC blockade using either anti-epileptic drugs or local anesthetics (LA) decreased the proliferation of cancer cells. LA increased cell line sensitivity to platinum and taxane chemotherapies. While lidocaine had similar additive effects with chemotherapy among EOC cells and fibroblasts, bupivacaine showed a more pronounced impact on EOC than fibroblasts when combined with either carboplatin (ΔAUC −37% vs. −16%, <i>p</i> = 0.003) or paclitaxel (ΔAUC −37% vs. −22%, <i>p</i> = 0.02). Together, these data suggest VGSC are prognostic biomarkers in EOC and may inform new targets for therapy.Iris S. BrummelhuisStephen J. FiasconeKathleen T. HasselblattGyorgy FrendlKevin M. EliasMDPI AGarticlehigh-grade serous ovarian cancersodium channelslocal anestheticsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5437, p 5437 (2021)
institution DOAJ
collection DOAJ
language EN
topic high-grade serous ovarian cancer
sodium channels
local anesthetics
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle high-grade serous ovarian cancer
sodium channels
local anesthetics
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Iris S. Brummelhuis
Stephen J. Fiascone
Kathleen T. Hasselblatt
Gyorgy Frendl
Kevin M. Elias
Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
description Abnormal ion channel expression distinguishes several types of carcinoma. Here, we explore the relationship between voltage-gated sodium channels (VGSC) and epithelial ovarian cancer (EOC). We find that EOC cell lines express most VGSC, but at lower levels than fallopian tube secretory epithelial cells (the cells of origin for most EOC) or control fibroblasts. Among patient tumor samples, lower <i>SCN8A</i> expression was associated with improved overall survival (OS) (median 111 vs. 52 months; HR 2.04 95% CI: 1.21–3.44; <i>p</i> = 0.007), while lower <i>SCN1B</i> expression was associated with poorer OS (median 45 vs. 56 months; HR 0.69 95% CI 0.54–0.87; <i>p</i> = 0.002). VGSC blockade using either anti-epileptic drugs or local anesthetics (LA) decreased the proliferation of cancer cells. LA increased cell line sensitivity to platinum and taxane chemotherapies. While lidocaine had similar additive effects with chemotherapy among EOC cells and fibroblasts, bupivacaine showed a more pronounced impact on EOC than fibroblasts when combined with either carboplatin (ΔAUC −37% vs. −16%, <i>p</i> = 0.003) or paclitaxel (ΔAUC −37% vs. −22%, <i>p</i> = 0.02). Together, these data suggest VGSC are prognostic biomarkers in EOC and may inform new targets for therapy.
format article
author Iris S. Brummelhuis
Stephen J. Fiascone
Kathleen T. Hasselblatt
Gyorgy Frendl
Kevin M. Elias
author_facet Iris S. Brummelhuis
Stephen J. Fiascone
Kathleen T. Hasselblatt
Gyorgy Frendl
Kevin M. Elias
author_sort Iris S. Brummelhuis
title Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
title_short Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
title_full Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
title_fullStr Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
title_full_unstemmed Voltage-Gated Sodium Channels as Potential Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer
title_sort voltage-gated sodium channels as potential biomarkers and therapeutic targets for epithelial ovarian cancer
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/835024f64c6d47a0aba2f1c716255950
work_keys_str_mv AT irissbrummelhuis voltagegatedsodiumchannelsaspotentialbiomarkersandtherapeutictargetsforepithelialovariancancer
AT stephenjfiascone voltagegatedsodiumchannelsaspotentialbiomarkersandtherapeutictargetsforepithelialovariancancer
AT kathleenthasselblatt voltagegatedsodiumchannelsaspotentialbiomarkersandtherapeutictargetsforepithelialovariancancer
AT gyorgyfrendl voltagegatedsodiumchannelsaspotentialbiomarkersandtherapeutictargetsforepithelialovariancancer
AT kevinmelias voltagegatedsodiumchannelsaspotentialbiomarkersandtherapeutictargetsforepithelialovariancancer
_version_ 1718435249349722112